NCT00003296View on ClinicalTrials.gov

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 1998

Conditions
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (2)

02111

New England Medical Center Hospital, Boston

02912

Brown University Oncology Group, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
lead

Brown University

OTHER

NCT00003296 - Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | Biotech Hunter | Biotech Hunter